The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years

por Martínez-Castelao, Alberto, Navarro-González, Juan F., Górriz, José Luis, de Alvaro, Fernando
Publicado 2015

Correction to: From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes

por Quiroga, Borja, Ortiz, Alberto, Navarro-González, Juan F, Santamaría, Rafael, de Sequera, Patricia, Díez, Javier
Publicado 2022

From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes

por Quiroga, Borja, Ortiz, Alberto, Navarro-González, Juan F, Santamaría, Rafael, de Sequera, Patricia, Díez, Javier
Publicado 2022

Inflammatory Cytokines in Diabetic Nephropathy

por Donate-Correa, Javier, Martín-Núñez, Ernesto, Muros-de-Fuentes, Mercedes, Mora-Fernández, Carmen, Navarro-González, Juan F.
Publicado 2015

Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?

por Górriz, Jose Luis, Nieto, Javier, Navarro-González, Juan F., Molina, Pablo, Martínez-Castelao, Alberto, Pallardó, Luis M.
Publicado 2015

Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease

por Donate-Correa, Javier, Martín-Carro, Beatriz, Cannata-Andía, Jorge B., Mora-Fernández, Carmen, Navarro-González, Juan F.
Publicado 2023

Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study

por Donate-Correa, Javier, Martín-Núñez, Ernesto, Mora-Fernández, Carmen, González-Luis, Ainhoa, Martín-Olivera, Alberto, Navarro-González, Juan F.
Publicado 2023

Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus

por Donate-Correa, Javier, Martín-Núñez, Ernesto, Mora-Fernández, Carmen, González-Luis, Ainhoa, Martín-Olivera, Alberto, Navarro-González, Juan F.
Publicado 2023

SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia

por Fernandez-Fernandez, Beatriz, Sarafidis, Pantelis, Kanbay, Mehmet, Navarro-González, Juan F, Soler, María José, Górriz, Jose Luis, Ortiz, Alberto
Publicado 2020

Electronic Patient-Reported Outcomes in Nephrology: Focus on Hemodialysis

por Pérez-Morales, Rosa, Buades-Fuster, Juan Manuel, Esteve-Simó, Vicent, Macía-Heras, Manuel, Mora-Fernández, Carmen, Navarro-González, Juan F.
Publicado 2022

The unmet need of evidence-based therapy for patients with advanced chronic kidney disease and heart failure: Position paper from the Cardiorenal Working Groups of the Spanish Soci...

por Ortiz, Alberto, Navarro-González, Juan F, Núñez, Julio, de la Espriella, Rafael, Cobo, Marta, Santamaría, Rafael, de Sequera, Patricia, Díez, Javier
Publicado 2021

Serum Phosphate Levels Modify the Impact of FGF23 Levels on Hemoglobin in Chronic Kidney Disease

por Navarro-González, Juan F., Mora-Fernández, Carmen, Diaz-Tocados, Juan Miguel, Bozic, Milica, Bermúdez-López, Marcelino, Martín, Marisa, Valdivielso, Jose Manuel
Publicado 2022

Sodium-glucose cotransporter 2 inhibition: towards an indication to treat diabetic kidney disease

por Górriz, Jose Luis, Navarro-González, Juan F, Ortiz, Alberto, Vergara, Ander, Nuñez, Julio, Jacobs-Cachá, Conxita, Martínez-Castelao, Alberto, Soler, Maria Jose
Publicado 2020

Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease

por Donate-Correa, Javier, Ferri, Carla M., Martín-Núñez, Ernesto, Pérez-Delgado, Nayra, González-Luis, Ainhoa, Mora-Fernández, Carmen, Navarro-González, Juan F.
Publicado 2021

Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease

por Donate‐Correa, Javier, Martín‐Núñez, Ernesto, Martínez‐Sanz, Rafael, Muros‐de‐Fuentes, Mercedes, Mora‐Fernández, Carmen, Pérez‐Delgado, Nayra, Navarro‐González, Juan F.
Publicado 2015

Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment...

por Fernandez-Fernandez, Beatriz, Fernandez-Prado, Raul, Górriz, Jose Luis, Martinez-Castelao, Alberto, Navarro-González, Juan F, Porrini, Esteban, Soler, María José, Ortiz, Alberto
Publicado 2019

Optimizing the timing of nephrology referral for patients with diabetic kidney disease

por Martínez-Castelao, Alberto, Soler, María José, Górriz Teruel, José Luis, Navarro-González, Juan F, Fernandez-Fernandez, Beatriz, de Alvaro Moreno, Fernando, Ortiz, Alberto
Publicado 2020

Should we adjust erythropoiesis-stimulating agent dosage to postdialysis hemoglobin levels? A pilot study

por Castillo, Nieves, García-García, Patricia, Rivero, Antonio, Jiménez-Sosa, Alejandro, Macía, Manuel, Getino, María Adela, Méndez, María Luisa, García-Pérez, Javier, Navarro-González, Juan F
Publicado 2012

Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications

por Donate-Correa, Javier, Ferri, Carla M., Sánchez-Quintana, Fátima, Pérez-Castro, Atteneri, González-Luis, Ainhoa, Martín-Núñez, Ernesto, Mora-Fernández, Carmen, Navarro-González, Juan F.
Publicado 2021

Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes

por Donate-Correa, Javier, Martín-Núñez, Ernesto, González-Luis, Ainhoa, Ferri, Carla M., Luis-Rodríguez, Desirée, Tagua, Víctor G., Mora-Fernández, Carmen, Navarro-González, Juan F.
Publicado 2021